{"log_id": 3862018888087224052, "direction": 0, "words_result_num": 26, "words_result": [{"probability": {"variance": 1e-05, "average": 0.998534, "min": 0.980839}, "location": {"width": 824, "top": 166, "height": 38, "left": 221}, "words": "素或噻吗洛尔单独用药。在两项为期6个月的双盲,对照临床试验中,对本品与拉坦前列素"}, {"probability": {"variance": 3e-05, "average": 0.997954, "min": 0.9668}, "location": {"width": 815, "top": 214, "height": 37, "left": 220}, "words": "或噻吗洛尔单剂治疗的降眼压作用进行了比较,入选病人眼压要求至少为25mmHg或更高"}, {"probability": {"variance": 0.001616, "average": 0.990267, "min": 0.740224}, "location": {"width": 824, "top": 260, "height": 38, "left": 220}, "words": "试验中,病人连续使用噻吗洛尔2-4周后(眼压比入组时平均下降5mmHg),接着分别使"}, {"probability": {"variance": 1.6e-05, "average": 0.997593, "min": 0.983339}, "location": {"width": 821, "top": 308, "height": 36, "left": 219}, "words": "用拉坦噻吗滴眼液、拉坦前列素和噻吗洛尔(每天两次)6个月,平均日间眼压进一步下降"}, {"probability": {"variance": 0.000287, "average": 0.99373, "min": 0.918728}, "location": {"width": 773, "top": 358, "height": 34, "left": 218}, "words": "31、2.0和0.6mmHg。本品的降眼压作用在随后延续6个月的开放性研究中仍然维持"}, {"probability": {"variance": 2.9e-05, "average": 0.9974, "min": 0.970337}, "location": {"width": 786, "top": 447, "height": 39, "left": 256}, "words": "现有的资料显示,夜间用药的降眼压疗效可能要优于早上用药。但是,在考虑向患者推"}, {"probability": {"variance": 5e-06, "average": 0.998525, "min": 0.988326}, "location": {"width": 687, "top": 496, "height": 32, "left": 216}, "words": "荐早上用药还是夜间用药时,应该充分考虑患者的生活方式和可能的依从性"}, {"probability": {"variance": 6.8e-05, "average": 0.997165, "min": 0.948243}, "location": {"width": 784, "top": 589, "height": 35, "left": 255}, "words": "应该谨记,研究结果显示,在拉坦噻吗滴眼液疗效不满意时,使用噻吗洛尔一天两次联"}, {"probability": {"variance": 1e-06, "average": 0.999189, "min": 0.996547}, "location": {"width": 339, "top": 637, "height": 27, "left": 215}, "words": "合拉坦前列素一天一次仍然可能有效"}, {"probability": {"variance": 7e-06, "average": 0.998564, "min": 0.987885}, "location": {"width": 783, "top": 729, "height": 36, "left": 254}, "words": "本品给药后1小时内起效,6至8小时达最大效果。重复给药治疗中每次给药后可维持"}, {"probability": {"variance": 1e-06, "average": 0.998877, "min": 0.996971}, "location": {"width": 260, "top": 776, "height": 25, "left": 213}, "words": "足够的降眼压效果达24小时"}, {"probability": {"variance": 6e-06, "average": 0.998149, "min": 0.993035}, "location": {"width": 116, "top": 869, "height": 26, "left": 216}, "words": "【药理毒理】"}, {"probability": {"variance": 3.6e-05, "average": 0.995579, "min": 0.985181}, "location": {"width": 86, "top": 916, "height": 26, "left": 211}, "words": "药理作用"}, {"probability": {"variance": 0.001699, "average": 0.992158, "min": 0.741568}, "location": {"width": 786, "top": 961, "height": 36, "left": 251}, "words": "本品含两种活性成份:拉坦前列素和马来酸噻吗洛尔。它们通过不同的作用机制降低增"}, {"probability": {"variance": 0.006176, "average": 0.981829, "min": 0.490801}, "location": {"width": 824, "top": 1006, "height": 36, "left": 211}, "words": "高的眼压(IOP)。与各成份单独使用相比,两种药物联合具有协同效应,能产生额外的降"}, {"probability": {"variance": 0, "average": 0.999312, "min": 0.998229}, "location": {"width": 85, "top": 1055, "height": 24, "left": 209}, "words": "眼压作用"}, {"probability": {"variance": 0.00038, "average": 0.994565, "min": 0.901728}, "location": {"width": 782, "top": 1146, "height": 36, "left": 248}, "words": "拉坦前列素为前列腺素F2a的类似物,它是一种选择性前列腺素FP受体激动剂,通过"}, {"probability": {"variance": 1.4e-05, "average": 0.998518, "min": 0.98133}, "location": {"width": 824, "top": 1193, "height": 35, "left": 206}, "words": "增加房水外流而降低眼压。主要作用机制为增加葡萄膜巩膜通路的房水外流。另外,也有报"}, {"probability": {"variance": 7e-06, "average": 0.99861, "min": 0.988828}, "location": {"width": 814, "top": 1239, "height": 36, "left": 207}, "words": "道本品能增加人类房水流出通畅系数(降低小梁网房水外流阻力)。拉坦前列素对房水生成"}, {"probability": {"variance": 0.000173, "average": 0.99674, "min": 0.91584}, "location": {"width": 826, "top": 1286, "height": 37, "left": 206}, "words": "血液一房水屏障或眼内血循环无明显影响。经荧光血管造影检查证实,行晶状体囊外摘除术"}, {"probability": {"variance": 1e-05, "average": 0.998468, "min": 0.980549}, "location": {"width": 826, "top": 1334, "height": 36, "left": 205}, "words": "的猴眼长期使用拉坦前列素不影响视网膜血管。在人类,人工晶状体眼病人短期使用拉坦前"}, {"probability": {"variance": 1e-06, "average": 0.999214, "min": 0.996954}, "location": {"width": 319, "top": 1384, "height": 26, "left": 205}, "words": "列素,不会引起后节的荧光素渗漏"}, {"probability": {"variance": 0.004198, "average": 0.980919, "min": 0.705792}, "location": {"width": 782, "top": 1476, "height": 35, "left": 246}, "words": "噻吗洛尔是一种β-1和β-2(非选择性)肾上腺素受体阻断剂,无明显内在拟交感活"}, {"probability": {"variance": 1.6e-05, "average": 0.997788, "min": 0.982358}, "location": {"width": 827, "top": 1522, "height": 37, "left": 203}, "words": "性、直接的心肌抑制作用或膜稳定作用。噻吗洛尔通过减少睫状上皮细胞产生房水而降低眼"}, {"probability": {"variance": 7.5e-05, "average": 0.993997, "min": 0.972574}, "location": {"width": 142, "top": 1579, "height": 24, "left": 549}, "words": "第11页,共14页"}, {"probability": {"variance": 0.000401, "average": 0.987442, "min": 0.933984}, "location": {"width": 97, "top": 1601, "height": 19, "left": 265}, "words": "No:2013050"}], "language": 3}